Using statistical pathway analysis of gene expression data and specialized expertise, AbaSci LLC delivers unique, high-value results linking proteins, diseases, and drugs to support: *repurposing therapeutics / indication discovery *identifying a molecular rationale for drug combinations providing a basis for patient enrollment criteria & personalized medicine *drug target discovery elucidating drug mechanism of action biomarker discovery - *type I/II diagnostics discovery
| Website | http://abasci.com/ |
| Revenue | $186.5 million |
| Employees | View employees |
| Technologies | |
| Industry | Biotechnology, Colleges & Universities, Education |
| Competitors | Bio-Rad Laboratories, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Inc., QIAGEN, BD, Illumina, MilliporeSigma, Promega Corporation, Roche +50 more (view full list) |
| SIC | SIC Code 82 Companies, SIC Code 822 Companies |
| NAICS | NAICS Code 61 Companies, NAICS Code 611 Companies |
Looking for a particular AbaSci employee's phone or email?
AbaSci Questions
The AbaSci annual revenue was $186.5 million in 2026.
The NAICS codes for AbaSci are [61, 611].
The SIC codes for AbaSci are [82, 822].
Related Companies
